PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 109 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,415,000 | +175.8% | 29,077 | +206.0% | 0.01% | +180.0% |
| Q3 2017 | $513,000 | -13.1% | 9,502 | -5.9% | 0.01% | -16.7% |
| Q2 2017 | $590,000 | +45.0% | 10,093 | -2.9% | 0.01% | +50.0% |
| Q1 2017 | $407,000 | -11.1% | 10,394 | -49.1% | 0.00% | 0.0% |
| Q4 2016 | $458,000 | -1.3% | 20,419 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $464,000 | -4.5% | 20,419 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $486,000 | +69.3% | 20,419 | +45.0% | 0.00% | +33.3% |
| Q1 2016 | $287,000 | -67.4% | 14,080 | -17.8% | 0.00% | -62.5% |
| Q4 2015 | $881,000 | +19.4% | 17,129 | -1.0% | 0.01% | +33.3% |
| Q3 2015 | $738,000 | -62.3% | 17,309 | -59.8% | 0.01% | -60.0% |
| Q2 2015 | $1,960,000 | +2030.4% | 43,035 | +1267.5% | 0.02% | +1400.0% |
| Q2 2014 | $92,000 | – | 3,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |